Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine in a Combination Package Compared to the Separate Intake of the Reference Brands Atacand and Splendil After a Fasting Period.
Phase of Trial: Phase I
Latest Information Update: 06 Dec 2010
At a glance
- Drugs Candesartan cilexetil; Felodipine
- Indications Heart failure; Hypertension
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 06 Dec 2010 Actual end date changed from Nov 2009 to Nov 2008 as reported by ClinicalTrials.gov.
- 19 May 2010 Actual initiation date changed from 1 Sep 2008 to 1 Oct 2008 as reported by ClinicalTrials.gov.
- 19 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.